Endophenotypes in Schizophrenia: Digging Deeper to Identify Genetic Mechanisms

Area of Science:

• Neuroscience
• Psychiatry
• Genetics

Background:

• Schizophrenia (SZ) is a severe, highly heritable psychotic disorder with substantial genetic and clinical heterogeneity.
• Genome-wide association studies have identified many SZ risk variants, but underlying biological pathways remain largely unknown.
• Clinical heterogeneity complicates identifying risk variants, necessitating stable neurobiological markers.

Purpose of the Study:

• To review promising neurocognitive and neurophysiological endophenotypes for schizophrenia research.
• To explore how these endophenotypes can help identify genetic risk variants and pathways.
• To discuss the translational potential of endophenotypes in animal models for evaluating neural circuit dysfunctions.

Main Methods:

• Review of selected schizophrenia endophenotypes: prepulse inhibition, mismatch negativity, oculomotor antisaccade, letter-number sequencing, and continuous performance tests.
• Highlighting recent findings from large consortia on gene associations with endophenotypes.
• Discussing the utility of endophenotypes for detecting genetic risk variants and underlying pathways.

Main Results:

• Endophenotypes offer a more stable and less heterogeneous measure of brain dysfunction compared to clinical SZ symptoms.
• Endophenotypes facilitate the detection of genetic risk variants and underlying biological pathways.
• Recent findings suggest roles for neuregulin and glutamate pathways in SZ endophenotypes.

Conclusions:

• Neurocognitive and neurophysiological endophenotypes are valuable tools for dissecting the genetic architecture of schizophrenia.
• Endophenotypes provide a neurobiological context to understand SZ risk variants and pathways.
• Further research using endophenotypes may reveal novel treatment targets for schizophrenia.